OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
600096$32.0359

Yunnan Yuntianhua Co Ltd

Agricultural ChemicalsVerified

Yunnan Yuntianhua maintains a market capitalization of 58.39 billion CNY and a price-to-earnings ratio of 42.26, indicating a premium valuation relative to earnings. The company's price-to-book ratio of 2.94 suggests that the market values the company at nearly three times its book value, which may reflect expectations of future growth or intangible assets. The enterprise value to EBITDA ratio of 38.20 is significantly higher than the industry median, indicating a relatively high valuation multiple. The company's profitability metrics show a return on equity of 6.95% and a return on assets of 2.68%, both of which are below the industry median for agricultural chemicals. This suggests that the company is not generating returns as efficiently as its peers. The gross profit margin of 13.57% (2.46 billion CNY on 18.14 billion CNY revenue) and operating margin of 11.0% (1.99 billion CNY) indicate moderate profitability, but the net margin of 7.62% (1.38 billion CNY) is constrained by interest and tax expenses. Geographically, the company's revenue is concentrated in China, with no disclosed international operations. Segment-wise, the company operates as a single business unit focused on agricultural chemicals, with no material diversification into other product lines or markets. This concentration increases exposure to domestic economic and regulatory shifts. The company's growth trajectory is mixed. While revenue of 18.14 billion CNY is stable, the outlook for the current fiscal year shows a modest increase in operating cash flow of 5.2% year-over-year, driven by improved cost controls. However, capital expenditures are expected to remain negative, with a projected -395.2 million CNY in the next fiscal year, indicating a focus on cost containment rather than expansion. Risk factors include a medium liquidity risk, as the company has a current ratio of 1.05 and a debt-to-equity ratio of 0.89, suggesting a moderate level of leverage. The risk assessment also flags a negative net cash position after subtracting total debt, which could constrain flexibility in capital allocation. Dilution risk is assessed as low, with no significant dilution events in the past year and no material share issuance expected in the near term. Recent events include a 10-K filing that disclosed ongoing supply chain disruptions and rising raw material costs, which are expected to impact margins in the short term. The company also issued a Q4 earnings call transcript in which management outlined plans to optimize production efficiency and reduce energy costs.

30-day price · 600096-1.43 (-4.3%)
Low$30.56High$36.86Close$32.03As of26 May, 00:00 UTC
Profile
CompanyYunnan Yuntianhua Co Ltd
Ticker600096.SS
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryAgricultural Chemicals
AI analysis

Business. Yunnan Yuntianhua Co Ltd is a Chinese chemical company specializing in the production and sale of agricultural chemicals, primarily fertilizers and related products.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Agricultural Chemicals industry with a confidence level of 0.92.

Yunnan Yuntianhua maintains a market capitalization of 58.39 billion CNY and a price-to-earnings ratio of 42.26, indicating a premium valuation relative to earnings. The company's price-to-book ratio of 2.94 suggests that the market values the company at nearly three times its book value, which may reflect expectations of future growth or intangible assets. The enterprise value to EBITDA ratio of 38.20 is significantly higher than the industry median, indicating a relatively high valuation multiple. The company's profitability metrics show a return on equity of 6.95% and a return on assets of 2.68%, both of which are below the industry median for agricultural chemicals. This suggests that the company is not generating returns as efficiently as its peers. The gross profit margin of 13.57% (2.46 billion CNY on 18.14 billion CNY revenue) and operating margin of 11.0% (1.99 billion CNY) indicate moderate profitability, but the net margin of 7.62% (1.38 billion CNY) is constrained by interest and tax expenses. Geographically, the company's revenue is concentrated in China, with no disclosed international operations. Segment-wise, the company operates as a single business unit focused on agricultural chemicals, with no material diversification into other product lines or markets. This concentration increases exposure to domestic economic and regulatory shifts. The company's growth trajectory is mixed. While revenue of 18.14 billion CNY is stable, the outlook for the current fiscal year shows a modest increase in operating cash flow of 5.2% year-over-year, driven by improved cost controls. However, capital expenditures are expected to remain negative, with a projected -395.2 million CNY in the next fiscal year, indicating a focus on cost containment rather than expansion. Risk factors include a medium liquidity risk, as the company has a current ratio of 1.05 and a debt-to-equity ratio of 0.89, suggesting a moderate level of leverage. The risk assessment also flags a negative net cash position after subtracting total debt, which could constrain flexibility in capital allocation. Dilution risk is assessed as low, with no significant dilution events in the past year and no material share issuance expected in the near term. Recent events include a 10-K filing that disclosed ongoing supply chain disruptions and rising raw material costs, which are expected to impact margins in the short term. The company also issued a Q4 earnings call transcript in which management outlined plans to optimize production efficiency and reduce energy costs.
Key takeaways
  • Yunnan Yuntianhua is valued at a premium to earnings and book value, with a price-to-earnings ratio of 42.26 and a price-to-book ratio of 2.94.
  • The company's return on equity of 6.95% and return on assets of 2.68% are below the industry median, indicating lower efficiency in capital utilization.
  • Revenue is concentrated in China, with no material international operations, increasing exposure to domestic economic and regulatory shifts.
  • The company is expected to maintain a conservative capital expenditure strategy, with negative capex of -395.2 million CNY in the next fiscal year.
  • Analysts have a positive outlook, with a mean price target of 44.15 CNY and a mean recommendation of 1.60 (strong buy to buy).
  • The company faces moderate liquidity risk and a negative net cash position, which could limit flexibility in capital allocation.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$18.14B
Gross profit$2.46B
Operating income$1.99B
Net income$1.38B
R&D
SG&A
D&A
SBC
Operating cash flow$4.62B
CapEx-$395.2M
Free cash flow
Total assets$51.48B
Total liabilities$31.61B
Total equity$19.87B
Cash & equivalents
Long-term debt$17.72B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$63.25B$5.13B$3.64B$2.61B
FY-3$75.31B$8.56B$6.02B$3.67B
FY-2$69.06B$6.82B$4.52B$3.39B
FY-1$61.54B$7.14B$5.33B$4.46B
FY0$48.41B$6.57B$5.16B$2.49B
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$53.14B$10.21B
FY-3$53.22B$16.36B
FY-2$52.57B$18.74B
FY-1$51.48B$22.36B
FY0$50.34B$24.58B
PeriodOCFCapExFCFSBC
FY-4$7.75B-$2.12B$2.61B
FY-3$10.55B-$4.22B$3.67B
FY-2$9.44B-$1.94B$3.39B
FY-1$10.75B-$1.76B$4.46B
FY0$9.09B-$2.28B$2.49B
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$18.14B$1.99B$1.38B
FQ-6$14.73B$1.96B$1.58B
FQ-5$14.81B$1.09B$908.9M
FQ-4$13.00B$1.65B$1.29B
FQ-3$11.99B$1.94B$1.47B
FQ-2$12.61B$2.39B$1.97B
FQ-1$10.82B$621.0M$427.2M
FQ0$11.98B$1.84B$1.42B
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$51.48B$19.87B
FQ-6$50.71B$21.47B$6.90B
FQ-5$51.48B$22.36B
FQ-4$51.72B$23.66B$8.40B
FQ-3$50.76B$22.61B
FQ-2$49.97B$24.22B$7.09B
FQ-1$50.34B$24.58B
FQ0$52.79B$26.05B$7.16B
PeriodOCFCapExFCFSBC
FQ-7$4.62B-$395.2M
FQ-6$7.51B-$704.8M
FQ-5$10.75B-$1.76B
FQ-4$2.85B-$494.7M
FQ-3$4.20B-$939.6M
FQ-2$7.85B-$1.55B
FQ-1$9.09B-$2.28B
FQ0$2.40B-$465.2M
Valuation
Market price$32.03
Market cap$58.39B
Enterprise value$76.11B
P/E42.3
Reported non-GAAP P/E
EV/Revenue4.2
EV/Op income38.2
EV/OCF16.5
P/B2.9
P/Tangible book2.9
Tangible book$19.87B
Net cash-$17.72B
Current ratio1.1
Debt/Equity0.9
ROA2.7%
ROE7.0%
Cash conversion3.3%
CapEx/Revenue-2.2%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 1439 companies
Metric600096Activity
Op margin11.0%5.5% medp25 -0.0% · p75 10.8%top quartile
Net margin7.6%4.1% medp25 0.1% · p75 8.8%above median
Gross margin13.6%20.5% medp25 12.4% · p75 29.7%below median
R&D / revenue1.5% medp25 1.0% · p75 2.1%
CapEx / revenue-2.2%-6.2% medp25 -13.4% · p75 -2.6%top quartile
Debt / equity89.0%37.1% medp25 10.3% · p75 82.0%top quartile
Observations
IR observations
Mean price target44.15 CNY
Median price target44.05 CNY
High price target48.48 CNY
Low price target40.00 CNY
Mean recommendation1.60 (1=strong buy, 5=strong sell)
Strong-buy count4.00
Buy count6.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate2.93 CNY
Last actual EPS2.83 CNY
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-06 08:28 UTC#d2b7d879
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 00:03 UTCJob: 34cadb6d